? As promised, a group of some 20 biopharma companies have pooled close to $1 billion to fund new research in antibiotics — a field that has been dying of late. Small margins and tiny markets have killed off a slate of players in the field and drove ou… […]
CHEMISTRY & BIOCHEMISTRY (100% Limited Appointment)Hiring Salary Range: $58,462 – $63,270/yearFiling Deadline: Thu 7/23/2020 […]
VelosBio’s experimental drug works a bit like a Trojan Horse, slipping inside cancer cells before destroying them […]
PSYCHIATRY/Geriatric Research (100% Career)Salary commensurate with qualifications and experienceFiling Deadline: Wed 7/22/2020 […]
Expect unfavorable events through analysis of data and prepare control strategies. Experience in collecting and analyzing data. $98,000 – $118,000 a yearFrom Indeed – Wed, 08 Jul 2020 16:19:41 GMT – View all San Diego, CA jobs […]
Previous working experience as a Supply Chain Manager for 5 years. Train and evaluate others, and provide constructive feedback. In addition, you will play a. $112,000 – $142,000 a yearFrom Indeed – Wed, 08 Jul 2020 16:16:50 GMT – View all San Diego, C… […]
? Zai Lab is paying out a $25 million upfront for the rights to sell Turning Point Therapeutics’ lead drug repotrectinib in Greater China. The San Diego-based biotech is also in line for up to $151 million in milestones, along with mid-to-high teen roy… […]
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) — Nascent Biotech, Inc. (OTC: NBIO) Announced today that its Senior Officers have converted the Company’s liability to them into common stock, reducing the liabilities of the Company by over $1.1 million. […]
LA JOLLA, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Cend Therapeutics, Inc. (formerly DrugCendR, Inc.), a clinical-stage biotech company, announced today changes in the senior management of the company. David Slack, MBA will take over as President an… […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes
